AR
Anupam Rama JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
IDEAYA Biosciences
IDYA
$2.38B
| $27.16 | $74 |
172%
upside
| Overweight | 3 days ago |
|
2
BridgeBio Pharma
BBIO
$10.2B
| $53.38 | $70 |
31%
upside
| Overweight | 3 days ago |
|
3
Solid Biosciences
SLDB
$428M
| $5.50 | $13 |
136%
upside
| Overweight | 23 days ago |
|
4
Oric Pharmaceuticals
ORIC
$1.06B
| $10.88 | $17 |
56%
upside
| Overweight | 23 days ago |
|
5
Olema Pharmaceuticals
OLMA
$570M
| $8.31 | $29 |
249%
upside
| Overweight | 23 days ago |
|
6
Kodiak Sciences
KOD
$556M
| $10.52 | $15 |
43%
upside
| Neutral | 24 days ago |
|
7
Vera Therapeutics
VERA
$1.54B
| $24.19 | $53 |
119%
upside
| Overweight | 1 month ago |
|
8
Cogent Biosciences
COGT
$1.82B
| $13.05 | $30 |
130%
upside
| Overweight | 1 month ago |
|
9
Apellis Pharmaceuticals
APLS
$3.55B
| $28.13 | $37 |
32%
upside
| Overweight | 1 month ago |
|
10
Neurocrine Biosciences
NBIX
$14.3B
| $144.10 | $145 |
1%
upside
| Neutral | 1 month ago |
|
11
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $24 |
28%
upside
| Neutral | 1 month ago |
|
12
AnaptysBio
ANAB
$613M
| $21.90 | $80 |
265%
upside
| Overweight | 1 month ago |
|
13
Replimune Group
REPL
$494M
| $6.33 | $9 |
42%
upside
| Neutral | 1 month ago |
|
14
Ultragenyx Pharmaceutical
RARE
$3.07B
| $31.82 | $117 |
268%
upside
| Overweight | 5 months ago |
|
15
Syndax Pharmaceuticals
SNDX
$1.47B
| $17.04 | $41 |
141%
upside
| Overweight | 5 months ago |
|
16
Zai Lab
ZLAB
$3.42B
| $30.76 | $51 |
66%
upside
| Overweight | 5 months ago |
|
17
Day One Biopharmaceuticals
DAWN
$773M
| $7.55 | $34 |
350%
upside
| Overweight | 6 months ago |
|
18
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $44 |
103%
upside
| Overweight | 6 months ago |
|
|
MAZE
19
Maze Therapeutics, Inc. Common Stock
MAZE
$696M
| $15.88 | $30 |
89%
upside
| Overweight | 6 months ago |
|
20
Amicus Therapeutics
FOLD
$2.46B
| $7.99 | $17 |
113%
upside
| Overweight | 9 months ago |
|
21
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $35.71 | $40 |
12%
upside
| Overweight | 10 months ago |
|
22
Nuvalent
NUVL
$5.83B
| $80.89 | $125 |
55%
upside
| Overweight | 11 months ago |
|
23
Cytokinetics
CYTK
$6.34B
| $53.01 | $58 |
9%
upside
| Overweight | 3 years ago |
|
24
Theravance Biopharma
TBPH
$703M
| $13.95 | $12 |
14%
downside
| Neutral | 3 years ago |
|
25
Vir Biotechnology
VIR
$732M
| $5.27 | $37 |
602%
upside
| Neutral | 3 years ago |
|